FDA approves Benlysta autoinjector for children with lupus nephritis
The U.S. Food and Drug Administration (FDA) has approved Benlysta (belimumab) in an autoinjector that can be used at home as an add-on treatment for children ages 5 and older with active lupus nephritis, a serious complication of lupus that causes inflammation and damage to the kidneys. This…